ARCS Weekly Wrap 19 September 2026

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a1/cc/9a/a1cc9a9e-a4bc-39aa-92d3-3cf6d0ab2b14/mza_15551501372172170772.jpg/600x600bb.jpg

Cognitio

ARCS Australia

27 episodes

3 days ago

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

Medicine

Health & Fitness

RSS

All content for Cognitio is the property of ARCS Australia and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43238377/43238377-1741754321693-fbfa5331b1537.jpg

ARCS Weekly Wrap 19 September 2026

Cognitio

5 minutes 41 seconds

1 month ago

ARCS Weekly Wrap 19 September 2026

Weekly News Wrap – 19 September 2025

This week’s ARCS Weekly News Wrap is packed with sector-shaping stories across pharma, medtech, biotech, and leadership. Tim Boyle recaps a milestone few days for ARCS, including a sold-out Leadership & Communications Symposium and a record turnout at our networking night with AMWA.

In pharma, Australian science takes the global stage with Pfizer’s breast cancer trial and CSL’s billion-dollar play with Dutch biotech VarmX. Medtech sees big advances as Epworth Eastern adopts robotic bronchoscopy, Siemens Healthineers launches a $9M MRI facility with the University of Sydney, and Avita Medical secures European approval for its RECELL GO device.

Biotech breakthroughs abound, with Oncosil, Alterity Therapeutics, Actinogen Medical, and Cleo Diagnostics all reporting promising progress, while Novartis doubles down on acquisitions. Leadership shifts at Ipsen, Clinigen, CSL, and Lilly round out the week, signalling fresh strategies in the sector.

Join us as we unpack what these developments mean for you and why being part of the ARCS community matters more than ever.